What's New
Duke Health Pituitary Experts Diagnose and Treat Undetected Pituitary Tumors
Allegra Austin spent decades searching for a reason behind her complicated medical symptoms, often dismissed by doctors who told her to simply “stop eating” because she was “too fat.” At Duke Health, neuroendocrinologist Leena Shahla, MD, listened to her concerns, ordered tests right away, and diagnosed her with three pituitary disorders caused by two hormone-secreting pituitary tumors, and the tumors were removed a month later. “Because of Dr. Shahla I changed all my doctors to Duke, and now I feel more at ease,” said Austin.
New Procedure Offers Hope to Some Patients with Lung Tumors
People whose cancer requires permanent removal of a lung may now have another option. Duke Health transplant and thoracic surgeons are among the few in the country using a new technique to remove centrally located lung tumors by removing the lung, taking out the tumor then returning the lung to the body. This procedure, called lung autotransplantation, offers several benefits, including improved lung function and a better quality of life after surgery. It also offers the possibility of surgical removal of tumors to people who cannot undergo permanent lung removal.
Advances in Lung Cancer Treatment Offer New Hope
Lung cancer is one of the most common cancers, but it’s also surrounded by a lot of stigma that can keep people from getting screened or seeking care. At the same time, there is a lot of reason for hope. New ways to detect lung cancer earlier and exciting advances in immunotherapy are helping people live longer and improving their quality of life.
As part of our ongoing Conversations in Cancer series, Duke Health medical oncologist Diane Reidy-Lagunes, MD, talks to Laura Alder, MD, a Duke medical oncologist who specializes in lung cancer, about lung cancer stigma, screening, and one of the most exciting new treatments for small cell lung cancer: BiTEs, or bispecific T-cell engager therapies.